Bio-Rad Laboratories Inc (BIO)
Official siteHEALTHCARE • MEDICAL DEVICES • NYSE
Market Cap: $9.69B
Last updated: Nov 17, 2026 at 4:20 PM ET
Bio-Rad Laboratories Inc (BIO) Stock Chart
Bio-Rad Laboratories (BIO) has a latest price of $358.24 on Nov 17, 2026, 9.6% below its 52-week high of $396.23. Its price rose 14.4% over the past 12 months. The month-end price rose 135.4% over the 10 years through Oct 2026, a compound annual rate of 8.9%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $804.82 in Aug 2021 and its lowest $158.08 in Oct 2016, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart BIO with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for BIO.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 1.7%, and over 6 months it rose 27.5%. The month-end price rose 35.2% over the 3 years through Oct 2026, a compound annual rate of 10.6%.
| Period | Change |
|---|---|
| 1 month | +1.5% |
| 3 months | -1.7% |
| 6 months | +27.5% |
| 12 months | +14.4% |
| 12 months, with dividends | +14.4% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +35.2% | +10.6% |
| 5 years | -53.2% | -14.1% |
| 10 years | +135.4% | +8.9% |
Price by Year
Its best calendar year was 2019, when the price rose 59.3%, and its weakest was 2022, when it fell 44.3%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $372.18 | +22.8% |
| 2025 | $302.99 | -7.8% |
| 2024 | $328.51 | +1.7% |
| 2023 | $322.89 | -23.2% |
| 2022 | $420.49 | -44.3% |
| 2021 | $755.57 | +29.6% |
| 2020 | $582.94 | +57.5% |
| 2019 | $370.03 | +59.3% |
| 2018 | $232.22 | -2.7% |
| 2017 | $238.67 | +30.9% |
Trading Range
The price is 3.7% below its 50-day average of $372.00 and 12.8% above its 200-day average of $317.63.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $358.24 | |
| 52-week high | $396.23 | -9.6% |
| 52-week low | $236.73 | +51.3% |
| 50-day average | $372.00 | -3.7% |
| 200-day average | $317.63 | +12.8% |
Price Risk
Over 3 years, its largest fall from a peak was 42.1%.
| Measure | Value |
|---|---|
| 1-year beta | 0.73 |
| Largest fall, 1 year | -27.2% |
| Largest fall, 3 years | -42.1% |
Valuation
Bio-Rad Laboratories traded at 30.5x earnings at the end of 2025, against a 5-year median of 31.2x and a 10-year median of 41.5x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About BIO
What is BIO's 1-year price change?
Bio-Rad Laboratories's price rose 14.4% over the past 12 months. With dividends included, the 12-month total return was 14.4%.
What is BIO's 5-year price change?
Bio-Rad Laboratories's month-end price fell 53.2% over the 5 years through Oct 2026, a compound annual decline of 14.1%. These figures leave out dividends.
What is BIO's 52-week high and low?
Bio-Rad Laboratories's 52-week high is $396.23 and its 52-week low is $236.73. Its latest price of $358.24 on Nov 17, 2026 is 9.6% below the high.
What is BIO's beta?
Bio-Rad Laboratories's 1-year beta against the S&P 500 is 0.73, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 27.2%.
Is the BIO chart free?
Yes. Advanced Charting for BIO is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
BIO pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors